Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-371-5 | CAS number: 171171-80-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
An assessment of the toxicokinetics behaviour of this material and also that of a close structural analogue of the substance has been conducted to the extent that can be derived from relevant available information.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
Additional information
JUSTIFICATION FOR USE OF READ-ACROSS DATA
While the target material has test data which can be used for toxicokinetics assessment, comparison of overall physico-chemical and toxicity profiles for a similar analogue material with a larger dataset indicates it is appropriate to also consider and apply read-across data from the structural analogue when discussing basic toxicokinetics (see read-across matrix, attached).
TEST MATERIAL(S)
The test material is magnesium alkyl salicylate salt. It is a brown sticky solid which is made commercially available in liquid form with a refined mineral oil. The test substance analogue comprises calcium alkyl salicylate, which is a purple flaky solid but again is made commercially available in liquid form with a refined mineral oil. Therefore the substances were both administered as a solution in the availablein vivostudies.
The low vapour pressure value of the neat substance (in both cases) shows that it is not volatile and therefore inhalation is not a significant route of exposure. The neat substance is not expected to undergo hydrolysis under physiological conditions. As a result, exposure to hydrolysis products, following oral ingestion, is not expected.
The test substance (and analogue) has a relatively high molecular weight (747g/moL - for main % component), which suggests absorption across biological membranes is unlikely. However, based on a moderately high octanol/water partition coefficient (5.64± 0.15 at 40 degrees Centigrade), the substance could theoretically partition across biological membranes. The available physicochemical data on the neat substance and toxicological data on the preparation of neat substance and carrier oil were reviewed and, although the presence of carrier oil in the studies was taken into account, the assessment of toxicokinetic behaviour was based solely on the neat substance.
ABSORPTION
While there are little data on the test material for repeat dose toxicity, the repeated dose oral toxicity study in rats for the closely related analogue material showed that the substance is absorbed via the gastrointestinal tract. The moderately high log octanol/water partition coefficient will also favour absorption of the substance from the gut. Publically available absorption, distribution, metabolism and excretion (ADME) data for the carrier oil shows very poor permeability across the dermal membrane. However, signs of absorption are seen in the skin sensitisation test in guinea pigs. This may be explained by the mild skin irritation produced by the substance since damage to the skin surface may enhance penetration of the substance through the skin to some extent. Low volatility of the substance suggests that the test material would not be available for inhalation. The target material is expected to behave similarly.
DISTRIBUTION
There is no evidence to suggest that the target substance is distributed systemically in oral studies, however there is some limited evidence of this occurring with the analogue material in a positive response in a skin sensitisation study in the guinea pig which suggests that the test material binds to carrier proteins in the circulatory system. The relatively high log octanol/water partition coefficient suggests that the substance may distribute into the adipose tissue and accumulate in body fat.
METABOLISM
The test substance is hydrolytically stable under physiological conditions and is likely to undergo further metabolism prior to excretion. The results of the long-term oral toxicity studies in the analogue material show evidence of an adaptive response in the livers of rats, which is normally associated with enhanced metabolism. The results of thein vitro genotoxicity assays in both materials, however, do not show any evidence that addition of the S9 metabolising system enhances or diminishes the activity of the substance.
EXCRETION
There is no evidence to indicate the route of excretion for this material but poorly water soluble products with high molecular weight are not likely to undergo urinary excretion, therefore biliary excretion may well be a significant route for this material. Any test material that is not absorbed will most likely be excreted in the faeces.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
